The current simplified clinical approach prioritizes free testosterone as the primary metric to optimize, with estradiol as the secondary metric, and decision-making is based on clinical symptoms and supporting biomarkers rather than protocol complexity
normativepending
Speaker
Unknown Speaker 2Evidence Quote
“Today we take a much more simple approach. So the first question is, should you or should you have your free testosterone being higher? That's the metric I care about, is free testosterone is the first most important, the second most important is estradiol.”
Source
Testosterone & Testosterone Replacement Therapy (TRT) | Dr. Peter Attia & Dr. Andrew Huberman— Huberman Lab ClipsCreated: 8/10/2026, 10:48:33 PM
Your notes
Loading notes...